ALKERMES | ALKS - Trade Creditors


ALKERMES reported $107.95M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Acadia Pharmaceuticals USD 10.9M 10.84M Dec/2025
ALKERMES USD 107.95M 39.95M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
J&J USD 11.99B 2.37B Dec/2025
Malin Corporation EUR 700K 200K Dec/2024
Merck USD 4.15B 102M Sep/2025
Minerva Neurosciences USD 640K 305K Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Otsuka Holdings JPY 225.56B 31.54B Dec/2025
Ovoca Bio EUR 186K 23K Jun/2025
Pfizer USD 5.02B 142M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025